Yes GLP-1 medications were originally developed for type 2 diabetes and have strong evidence for improving blood sugar, reducing A1C, and protecting cardiovascular and kidney health
Never stop your medication without consulting both your prescribing physician and eye doctor first
Particularly, if most of the brain is not accessible to GLP1 or GLP1 receptor agonists from the circulation as discussed earlier, this raises the question of which source of GLP1 might reach these receptors
A consumer adhesive patch offers neither a standardized dose nor a proven path across the skin, which is the entire problem in a single sentence
The right dosage is crucial for optimal effectiveness, and our team at MedBridge tailors the dosage according to the individuals health needs, response to the medication, and specific weight loss goals